Exousia Bio LMMY Cash Flow Statement (2022-2026)

OTC LMMY
$0.02 +0.00 (+26.67%)
At close: Sep 2, 2026 · 4:00 PM EDT
Reported Financials

Exousia Bio Quarterly Cash Flow Statement

Periods 15 quarters
Latest Feb 2026

Exousia Bio cash flow statement data for the quarter ended Feb 2026. This cash flow statement covers 15 quarters of results from Aug 2022 through Feb 2026, standardized by Business Quant from the company’s SEC filings.

Cash Flow Statement Aug2022 Nov2022 Feb2023 May2023 Aug2023 Nov2023 Feb2024 May2024 Aug2024 Nov2024 Feb2025 May2025 Aug2025 Nov2025 Feb2026
Operating Activities
Net Income -0.01M-0.01M-0.01M-0.03M-0.01M-0.00M-0.00M-0.01M-0.00M0.08M0.08M-0.05M-0.03M-0.02M-0.02M
Asset Writedowns and ImpairmentWritedown 0.07M
Cash from OperationsCash from Ops. -0.01M-0.00M-0.00M-0.02M-0.01M-0.00M-0.00M-0.00M-0.00M0.09M-0.09M0.00M0.17M
Depreciation, Depletion & Amortization
Amortizatization of IntangiblesAmort. of Intangibles 0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M
Change in Working Capital
Change in ReceivablesChange Receivables 0.00M0.00M0.00M0.00M-0.01M-0.01M
Change in Account PayablesChange Payables 0.00M0.00M0.01M0.00M-0.00M-0.03M0.03M-0.03M
Change in Accured ExpensesChange Accured Exp. 610.00535.00924.000.00M-0.00M0.00M-0.00M0.00M0.18M
Investing Activities
Capital ExpendituresCapex -0.00M0.00M670.00
Cash from Investing ActivitiesCash from Investing 0.00M-0.00M-22.05M
Financing Activities
Cash from Financing ActivitiesCash from Financing 975.000.00M0.00M0.03M0.00M0.00M0.00M0.00M-0.09M0.09M-0.00M21.88M
Change in Capital Stock
Net Equity Issued and RepurchasedNet Equity Issued 0.00M0.02M
Additional items
Change in Cash -0.01M-435.000.00M0.00M-0.01M-290.00-2.002.00-0.00M
Free Cash FlowFCF -0.01M-0.00M-0.00M-0.02M-0.01M-0.00M-0.00M-0.00M-0.00M0.09M-0.09M0.00M0.17M
Net Cash FlowNCF -0.01M-435.000.00M0.00M-0.01M-290.00-2.002.00-0.00M-1.00